EP1161237A4 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- EP1161237A4 EP1161237A4 EP00917997A EP00917997A EP1161237A4 EP 1161237 A4 EP1161237 A4 EP 1161237A4 EP 00917997 A EP00917997 A EP 00917997A EP 00917997 A EP00917997 A EP 00917997A EP 1161237 A4 EP1161237 A4 EP 1161237A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12465999P | 1999-03-16 | 1999-03-16 | |
US124659P | 1999-03-16 | ||
PCT/US2000/006888 WO2000054769A1 (en) | 1999-03-16 | 2000-03-16 | Protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1161237A1 EP1161237A1 (en) | 2001-12-12 |
EP1161237A4 true EP1161237A4 (en) | 2002-03-27 |
Family
ID=22416114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00917997A Withdrawn EP1161237A4 (en) | 1999-03-16 | 2000-03-16 | Protease inhibitors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1161237A4 (en) |
JP (1) | JP2002539160A (en) |
AR (1) | AR022927A1 (en) |
AU (1) | AU3888200A (en) |
CO (1) | CO5180542A1 (en) |
HK (1) | HK1043534A1 (en) |
PE (1) | PE20001564A1 (en) |
UY (1) | UY26026A1 (en) |
WO (1) | WO2000054769A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
EP1229914A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Protease inhibitors |
WO2001034600A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
NZ520588A (en) | 2000-03-21 | 2004-06-25 | Smithkline Beecham Corp | Protease inhibitors |
WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
JP2004196696A (en) * | 2002-12-18 | 2004-07-15 | Kyowa Hakko Kogyo Co Ltd | Arthritis-preventing or treating agent |
PL2714675T3 (en) * | 2011-05-27 | 2019-07-31 | Lexicon Pharmaceuticals, Inc. | 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004172A1 (en) * | 1992-08-20 | 1994-03-03 | Prototek, Inc. | Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
EP0603769A1 (en) * | 1992-12-25 | 1994-06-29 | Mitsubishi Chemical Corporation | Alpha-Aminoketone derivatives |
-
2000
- 2000-02-23 UY UY26026A patent/UY26026A1/en unknown
- 2000-03-14 AR ARP000101121A patent/AR022927A1/en unknown
- 2000-03-16 CO CO00019250A patent/CO5180542A1/en not_active Application Discontinuation
- 2000-03-16 EP EP00917997A patent/EP1161237A4/en not_active Withdrawn
- 2000-03-16 WO PCT/US2000/006888 patent/WO2000054769A1/en not_active Application Discontinuation
- 2000-03-16 PE PE2000000226A patent/PE20001564A1/en not_active Application Discontinuation
- 2000-03-16 AU AU38882/00A patent/AU3888200A/en not_active Abandoned
- 2000-03-16 JP JP2000604845A patent/JP2002539160A/en not_active Withdrawn
-
2002
- 2002-05-13 HK HK02103606.8A patent/HK1043534A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004172A1 (en) * | 1992-08-20 | 1994-03-03 | Prototek, Inc. | Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
EP0603769A1 (en) * | 1992-12-25 | 1994-06-29 | Mitsubishi Chemical Corporation | Alpha-Aminoketone derivatives |
Non-Patent Citations (1)
Title |
---|
See also references of WO0054769A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1161237A1 (en) | 2001-12-12 |
JP2002539160A (en) | 2002-11-19 |
CO5180542A1 (en) | 2002-07-30 |
HK1043534A1 (en) | 2002-09-20 |
UY26026A1 (en) | 2000-10-31 |
AU3888200A (en) | 2000-10-04 |
PE20001564A1 (en) | 2001-02-08 |
WO2000054769A1 (en) | 2000-09-21 |
AR022927A1 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL349192A1 (en) | Protease inhibitors | |
IL146518A0 (en) | Metalloprotease inhibitors | |
IL150964A0 (en) | Protease inhibitors | |
EP1093367A4 (en) | Protease inhibitors | |
IL145085A0 (en) | Dihetero-substituted metalloprotease inhibitors | |
EP1067894A4 (en) | Protease inhibitors | |
EP1235577A4 (en) | Protease inhibitors | |
EP1079821A4 (en) | Protease inhibitors | |
IL153421A0 (en) | Protease inhibitors | |
EP1232155A4 (en) | Protease inhibitors | |
EP1229914A4 (en) | Protease inhibitors | |
EP1229915A4 (en) | Protease inhibitors | |
EP1229912A4 (en) | Protease inhibitors | |
EP1231921A4 (en) | Protease inhibitors | |
EP1140897A4 (en) | Protease inhibitors | |
EP1086083A4 (en) | Protease inhibitors | |
IL151087A0 (en) | Protease inhibitors | |
EP1351930A4 (en) | Protease inhibitors | |
EP1173429A4 (en) | Protease inhibitors | |
HK1043534A1 (en) | Protease inhibitors | |
EP1233771A4 (en) | Protease inhibitors | |
EP1229911A4 (en) | Protease inhibitors | |
EP1231923A4 (en) | Protease inhibitors | |
EP1231922A4 (en) | Protease inhibitors | |
EP1232154A4 (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010914 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020212 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/357 A, 7C 07D 321/06 B, 7C 07D 407/12 B, 7C 07D 409/12 B, 7C 07D 495/14 B |
|
17Q | First examination report despatched |
Effective date: 20020523 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20021003 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1043534 Country of ref document: HK |